| 000 | 01744 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515081029.0 | ||
| 264 | 0 | _c20080414 | |
| 008 | 200804s 0 0 eng d | ||
| 022 | _a0378-5173 | ||
| 024 | 7 |
_a10.1016/j.ijpharm.2007.07.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPalmberger, Thomas F | |
| 245 | 0 | 0 |
_aThiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir. _h[electronic resource] |
| 260 |
_bInternational journal of pharmaceutics _cFeb 2008 |
||
| 300 |
_a54-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAcyclovir _xadministration & dosage |
| 650 | 0 | 4 |
_aAdjuvants, Pharmaceutic _xchemical synthesis |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCaco-2 Cells |
| 650 | 0 | 4 |
_aChitin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCimetidine _xmetabolism |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
| 650 | 0 | 4 | _aElectric Impedance |
| 650 | 0 | 4 |
_aGlutathione _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntestinal Absorption _xdrug effects |
| 650 | 0 | 4 |
_aIntestinal Mucosa _xdrug effects |
| 650 | 0 | 4 |
_aIntestine, Small _xdrug effects |
| 650 | 0 | 4 |
_aPropranolol _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aTablets |
| 650 | 0 | 4 |
_aVerapamil _xpharmacology |
| 700 | 1 | _aHombach, Juliane | |
| 700 | 1 | _aBernkop-Schnürch, Andreas | |
| 773 | 0 |
_tInternational journal of pharmaceutics _gvol. 348 _gno. 1-2 _gp. 54-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijpharm.2007.07.004 _zAvailable from publisher's website |
| 999 |
_c17247344 _d17247344 |
||